Journey Medical (DERM)

• Market cap: $220M
• 1 day: -4.6%
• 5 days: -8.8%
• 1 month: -22%
• 3 months: -17.23%
• 6 months: -9.18%
• Year to date: -11.01%
• 1 year: 19.03%
• 5 years: -30.21%
• 10 years: -30.21%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Employees: 41